Comparing high and low dose iron for people on peritoneal dialysis
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on peritoneal dialysis for at least 4 weeks and are expected to stay on it.
- Your iron levels (ferritin and transferrin saturation) are below certain limits.
- You have not had intravenous iron in the last 4 weeks.
- You are not pregnant and use effective birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an intravenous iron medication (iron isomaltoside) can improve anemia in patients on peritoneal dialysis. It may help those whose iron levels are low despite stable use of other anemia treatments.
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
This study compares two different doses of IV iron (low vs high) to see which works better for people with heart failure and low iron levels. It may help you feel less tired and breathe easier.
This study tests whether giving intravenous iron improves symptoms, quality of life, and exercise ability in people with heart failure and low iron levels. Participants will receive iron infusions and be monitored over time to see if their condition improves.
This study tests whether intravenous (IV) iron therapy can help older adults who have heart failure with preserved pumping function and low iron levels. It aims to improve symptoms and quality of life.
This study tests a new iron medicine (Ferric Bepectate) against an existing one (Ferric Carboxymaltose) to see if it works just as well for people with iron deficiency anemia. It aims to help patients with low iron and low hemoglobin get effective treatment.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.